Aemetis, Inc. (NASDAQ:AMTX) Holdings Lowered by Stifel Financial Corp

Stifel Financial Corp reduced its stake in shares of Aemetis, Inc. (NASDAQ:AMTX - Free Report) by 66.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 138,791 shares of the specialty chemicals company's stock after selling 280,703 shares during the period. Stifel Financial Corp owned about 0.27% of Aemetis worth $373,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in AMTX. Barclays PLC grew its holdings in Aemetis by 274.6% during the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company's stock worth $109,000 after acquiring an additional 34,816 shares in the last quarter. Clear Harbor Asset Management LLC acquired a new position in Aemetis during the 4th quarter worth $44,000. SG Americas Securities LLC acquired a new position in Aemetis during the 4th quarter worth $87,000. Bank of New York Mellon Corp grew its holdings in Aemetis by 29.6% during the 4th quarter. Bank of New York Mellon Corp now owns 91,880 shares of the specialty chemicals company's stock worth $247,000 after acquiring an additional 20,961 shares in the last quarter. Finally, Intech Investment Management LLC acquired a new position in Aemetis during the 4th quarter worth $46,000. 27.02% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages have weighed in on AMTX. UBS Group decreased their price objective on shares of Aemetis from $2.50 to $2.20 and set a "buy" rating for the company in a report on Friday, May 9th. StockNews.com raised shares of Aemetis to a "sell" rating in a report on Wednesday, February 5th. Ascendiant Capital Markets lifted their price target on shares of Aemetis from $18.00 to $19.00 and gave the company a "buy" rating in a report on Monday, March 17th. Finally, HC Wainwright reaffirmed a "buy" rating and issued a $28.00 price target on shares of Aemetis in a report on Friday, March 14th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $13.18.

Aemetis Stock Performance

Shares of NASDAQ AMTX traded down $0.01 during midday trading on Monday, hitting $1.69. The company's stock had a trading volume of 923,093 shares, compared to its average volume of 725,508. Aemetis, Inc. has a 1-year low of $1.22 and a 1-year high of $4.73. The firm's fifty day moving average price is $1.59 and its 200-day moving average price is $2.34. The firm has a market cap of $93.57 million, a P/E ratio of -0.75 and a beta of 1.47.

Aemetis (NASDAQ:AMTX - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The specialty chemicals company reported ($0.47) earnings per share for the quarter, missing the consensus estimate of ($0.39) by ($0.08). The company had revenue of $42.89 million for the quarter, compared to analysts' expectations of $59.35 million. During the same quarter in the previous year, the company posted ($0.58) EPS. As a group, research analysts predict that Aemetis, Inc. will post -2.07 earnings per share for the current fiscal year.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.